For related articles and more information, please visit OCA’s Health Issues page and our Appetite For a Change page.

The video above features Barbara Loe-Fisher, co-founder and president of the National Vaccine Information Center (NVIC), a non-profit charity dedicated to preventing vaccine injuries and deaths through public education and defending the legal right for everyone to make vaccine choices.

In her video, Barbara discusses how “a localized Ebola outbreak has been turned into a global public health emergency,” and why there’s reason to suspect that American and international authorities did not actually want Ebola to be confined to a few African nations.

US public health officials now warn that Ebola-a highly contagious and deadly hemorrhagic fever-type disease-might become as widespread as HIV/AIDS.

And while public health officials have alternative downplayed and hyped up fears about Ebola, there are actually few reasons why Ebola should turn into a full-blown deadly epidemic in developed countries like the US with strong health care infrastructures.

So far, only one Ebola infected person, a citizen from Liberia visiting the U.S., has died on American soil. He was originally misdiagnosed at a Dallas community hospital, which delayed treatment and there are questions about whether the inappropriate antibiotics he was given may have contributed to his early demise.

Regardless, by rousing fears about Ebola (which had killed about 5,000 people in West Africa by Nov. 1, 2014), vaccine manufacturers co-developing experimental genetically engineered Ebola vaccines with federal health agencies are now in a better position to fast-track licensure of Ebola vaccines.1 If Ebola vaccine makers are shielded from product liability lawsuits2 in the event people are injured or killed by their vaccine, their profits will be substantial.3

But, in order to get indemnification for a fast-tracked vaccine, the government must recommend the vaccine for universal use in children or adults or designate it as a “bioterrorism” vaccine needed to protect national security – as was the case with the 2009 swine flu pandemic H1N1 vaccine.